Sagimet Biosciences (SGMT) Cash from Operations (2023 - 2024)
Historic Cash from Operations for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to -$19.6 million.
- Sagimet Biosciences' Cash from Operations fell 40448.57% to -$19.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$38.5 million, marking a year-over-year change of. This contributed to the annual value of -$42.4 million for FY2024, which is 7855.34% down from last year.
- Sagimet Biosciences' Cash from Operations amounted to -$19.6 million in Q3 2024, which was down 40448.57% from -$5.6 million recorded in Q2 2024.
- Sagimet Biosciences' 5-year Cash from Operations high stood at -$3.9 million for Q3 2023, and its period low was -$19.6 million during Q3 2024.